Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Microchip-based Immunomagnetic Detection Of Circulating Tumor Cells.

Kazunori Hoshino, Yu-Yen Huang, N. Lane, M. Huebschman, J. Uhr, E. Frenkel, X. Zhang
Published 2011 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Screening for circulating tumor cells (CTCs) in blood has been an object of interest for evidence of progressive disease, status of disease activity, recognition of clonal evolution of molecular changes and for possible early diagnosis of cancer. We describe a new method of microchip-based immunomagnetic CTC detection, in which the benefits of both immunomagnetic assay and the microfluidic device are combined. As the blood sample flows through the microchannel closely above arrayed magnets, cancer cells labeled with magnetic nanoparticles are separated from blood flow and deposited at the bottom wall of the glass coverslip, which allows direct observation of captured cells with a fluorescence microscope. A polydimethylsiloxane (PDMS)-based microchannel fixed on a glass coverslip was used to screen blood samples. The thin, flat dimensions of the microchannel, combined with the sharp magnetic field gradient in the vicinity of arrayed magnets with alternate polarities, lead to an effective capture of labeled cells. Compared to the commercially available CellSearch™ system, fewer (25%) magnetic particles are required to achieve a comparable capture rate, while the screening speed (at an optimal blood flow rate of 10 mL h(-1)) is more than five times faster than those reported previously with a microchannel-based assay. For the screening experiment, blood drawn from healthy subjects into CellSave™ tubes was spiked with cultured cancer cell lines of COLO205 and SKBR3. The blood was then kept at room temperature for 48 hours before the screening, emulating the actual clinical cases of blood screening. Customized Fe(3)O(4) magnetic nanoparticles (Veridex Ferrofluid™) conjugated to anti-epithelial cell adhesion molecule (EpCAM) antibodies were introduced into the blood samples to label cancer cells, and the blood was then run through the microchip device to capture the labelled cells. After capture, the cells were stained with fluorescent labelled anti-cytokeratin, DAPI and anti-CD45. Subsequent immunofluorescence images were taken for the captured cells, followed by comprehensive computer aided analysis based on fluorescence intensities and cell morphology. Rare cancer cells (from ∼1000 cells down to ∼5 cells per mL) with very low tumor cell to blood cell ratios (about 1 : 10(7) to 10(9), including red blood cells) were successfully detected. Cancer cell capture rates of 90% and 86% were demonstrated for COLO205 and SKBR3 cells, respectively.
This paper references
Enhanced detection of grametocytes by magnetic deposition microscopy predicts higher potential for Palsmodium falciparum
S. Karl (2008)
Cancer’s circulation
J. Kaiser (2010)
10.1007/S10967-010-0488-6
Study of magnetic ferrite nanoparticles labeled with 99mTc-pertechnetate
A. Wang (2010)
10.1096/fj.05-5122fje
Hemoglobin degradation in malaria‐infected erythrocytes determined from live cell magnetophoresis
L. Moore (2006)
10.1155/2010/617421
Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer
M. C. Miller (2010)
Circulating tumor cells versus imaging—predicting overall survival in metastatic breast cancer, Clin
G. T. Budd (2006)
10.1073/pnas.1012539107
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
S. Stott (2010)
Terstappen and
D. Euhus E. Racila (1991)
10.1073/PNAS.95.8.4589
Detection and characterization of carcinoma cells in the blood.
E. Racila (1998)
10.1007/s10544-009-9305-9
Microdevice for the isolation and enumeration of cancer cells from blood
S. J. Tan (2009)
10.1186/1475-2875-7-66
Enhanced detection of gametocytes by magnetic deposition microscopy predicts higher potential for Plasmodium falciparum transmission
Stephan Karl (2008)
10.1073/pnas.0813188106
Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device
Amirali H. Talasaz (2009)
10.1088/0960-1317/13/4/324
Microfabricated electrolysis pump system for isolating rare cells in blood
Vasile I. Furdui (2003)
10.1002/ijc.23717
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor‐specific fluorescent ligands
W. He (2008)
10.1200/JCO.2004.22.14_SUPPL.9541
Expression of epithelial cell adhesion molecule in carcinoma cells present in blood and primary and metastatic tumors.
C. Rao (2005)
10.1016/J.CANLET.2006.12.014
Circulating tumor cells (CTC) detection: clinical impact and future directions.
P. Paterlini-Bréchot (2007)
10.1039/B513005K
Magnetism and microfluidics.
N. Pamme (2006)
10.1088/0960-1317/15/12/012
Simulations of dynamic self-assembly of paramagnetic microspheres in confined microgeometries
D. Liu (2005)
Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant.
T. Fehm (2002)
10.1039/b816986a
Micromagnetic-microfluidic blood cleansing device.
C. Yung (2009)
10.1126/science.327.5969.1072
Medicine. Cancer's circulation problem.
J. Kaiser (2010)
10.1038/nature06385
Isolation of rare circulating tumour cells in cancer patients by microchip technology
S. Nagrath (2007)
10.1016/0022-1759(91)90315-7
An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils.
T. Hansel (1991)
10.1007/S10544-006-0033-0
Combined microfluidic-micromagnetic separation of living cells in continuous flow
N. Xia (2006)
10.1039/B409366F
Immunomagnetic T cell capture from blood for PCR analysis using microfluidic systems.
Vasile I. Furdui (2004)
10.1158/1078-0432.CCR-05-1769
Circulating Tumor Cells versus Imaging—Predicting Overall Survival in Metastatic Breast Cancer
G. Budd (2006)
10.1016/S0304-8853(00)01254-3
Optimization of ferrofluids and protocols for the enrichment of breast tumor cells in blood
P. Liberti (2001)
10.1016/j.ctrv.2009.03.004
Circulating tumor cells (CTCs): detection methods and their clinical relevance in breast cancer.
B. Mostert (2009)
10.1002/(SICI)1097-0320(19990801)36:4<294::AID-CYTO3>3.0.CO;2-C
Detection of rare MCF-7 breast carcinoma cells from mixtures of human peripheral leukocytes by magnetic deposition analysis.
B. Fang (1999)
10.1088/0022-3727/36/13/201
TOPICAL REVIEW: Applications of magnetic nanoparticles in biomedicine
Q. Pankhurst (2003)
10.1158/1078-0432.CCR-10-1105
Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells
H. Lin (2010)
10.1021/AC00116A014
Analytical magnetapheresis of ferritin-labeled lymphocytes.
Maciej Zborowski (1995)
10.1073/PNAS.92.2.537
Model study detecting breast cancer cells in peripheral blood mononuclear cells at frequencies as low as 10(-7).
H. J. Gross (1995)
10.1023/A:1011490627871
Development and Characterization of Microfluidic Devices and Systems for Magnetic Bead-Based Biochemical Detection
Jin-Woo Choi (2001)
10.1021/mp9000519
Confocal images of circulating tumor cells obtained using a methodology and technology that removes normal cells.
P. Balasubramanian (2009)
10.1016/J.JMMM.2009.02.062
Microfabricated magnetic sifter for high-throughput and high-gradient magnetic separation.
Christopher M. Earhart (2009)
10.1200/JCO.2007.15.8923
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.
S. Cohen (2008)
Terstappen , Significance of circulating tumor cells detected by the CellSearch system in patients with metastatic breast colorectal and prostate cancer
G. V. Doyle (2006)
10.1158/1078-0432.CCR-04-0378
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
W. Allard (2004)



This paper is referenced by
10.1021/nn5004277
Emerging Role of Nanomaterials in Circulating Tumor Cell Isolation and Analysis
H. J. Yoon (2014)
10.1002/smll.201400719
A radial flow microfluidic device for ultra-high-throughput affinity-based isolation of circulating tumor cells.
Vasudha Murlidhar (2014)
10.1109/TDEI.2015.7116335
Disposable microfluidic channel with dielectric layer on PCB for AC sensing of biological cells
Jinhong Guo (2015)
10.14288/1.0073460
Automated microfluidic device for the separation of cancer cells from blood
B. K. Lin (2012)
10.1002/cam4.3077
Magnetically driven microfluidics for isolation of circulating tumor cells
L. Luo (2020)
10.1039/C6AN01739H
Recognition of tumor cells by immuno-SERS-markers in a microfluidic chip at continuous flow.
I. Freitag (2016)
Chapter 2 Recent Development of Cell Analysis on Micro fl udics
Ziyi He (2019)
10.1039/c2lc21168h
Droplet-based interfacial capacitive sensing.
B. Nie (2012)
10.1089/NAT.2016.0632
Aptamers: Promising Tools for the Detection of Circulating Tumor Cells.
Eman M. Hassan (2016)
10.1007/s10439-019-02256-7
Microfluidics-Based Organism Isolation from Whole Blood: An Emerging Tool for Bloodstream Infection Diagnosis
A. Burklund (2019)
10.1007/s10404-019-2316-9
An integrated microfluidic chip for generation and transfer of reactive species using gas plasma
O. Ogunyinka (2020)
10.1021/ac3031543
Micro total analysis systems: fundamental advances and applications in the laboratory, clinic, and field.
Michelle L Kovarik (2013)
10.1016/j.tibtech.2014.01.003
Point-of-care technologies for molecular diagnostics using a drop of blood.
Y. Song (2014)
10.1021/acs.analchem.6b00377
Photonic Lab-on-a-Chip: Integration of Optical Spectroscopy in Microfluidic Systems.
Isaac Rodríguez-Ruiz (2016)
Acoustofluidic rare cell sample preparation
Maria Antfolk (2015)
10.1038/srep29407
Paramagnetic Structures within a Microfluidic Channel for Enhanced Immunomagnetic Isolation and Surface Patterning of Cells
C. Sun (2016)
10.1002/jbm.b.34595
Antibody-modified magnetic nanoparticles as specific high-efficient cell-separation agents.
A. Saei (2020)
10.1002/pmic.201200411
Microfluidic devices for high‐throughput proteome analyses
Tzu-Chiao Chao (2013)
10.1002/9781119244554.CH9
Nanovelcro Cell‐Affinity Assay for Detecting and Characterizing Circulating Tumor Cells
Millicent Lin (2016)
Patterned nanomagnets on-chip for screening circulating tumor cells in blood
Yu-Yen Huang (2012)
10.1016/j.aca.2011.12.050
On-line sample pre-concentration in microfluidic devices: a review.
B. Giordano (2012)
10.1063/1.5017714
Geometrically enhanced sensor surfaces for the selective capture of cell-like particles in a laminar flow field.
F. Scherag (2018)
10.1007/978-3-319-13188-7_55-1
Application of Nanoparticles in Manufacturing
Qin Hu (2015)
10.2116/analsci.31.867
Microdevice in Cellular Pathology: Microfluidic Platforms for Fluorescence in situ Hybridization and Analysis of Circulating Tumor Cells.
Ken Sato (2015)
Manipulation of particles in a Hele-Shaw cell using sources and sinks
Antaran Deka (2018)
Surface Engineered Biosensors For The Early Detection Of Cancer
M. Islam (2016)
10.1002/smll.201300169
Magneto-controllable capture and release of cancer cells by using a micropillar device decorated with graphite oxide-coated magnetic nanoparticles.
Xiaolei Yu (2013)
10.1007/978-3-662-59596-1_4
Using Integrated Cancer-on-Chip Platforms to Emulate and Probe Various Cancer Models
Ziqiu Tong (2019)
10.1039/c8bm00864g
Effective reduction of non-specific binding of blood cells in a microfluidic chip for isolation of rare cancer cells.
D. Yu (2018)
Size-selective Circulating Tumor Cell Isolation on a Centrifugal Microfluidic Device
Ada Lee (2014)
10.7150/ntno.22091
Nanotechnology-Based Strategies for Early Cancer Diagnosis Using Circulating Tumor Cells as a Liquid Biopsy
Qinqin Huang (2018)
10.1039/c2lc21273k
Microfluidic approaches for cancer cell detection, characterization, and separation.
Jian Chen (2012)
See more
Semantic Scholar Logo Some data provided by SemanticScholar